Association of Dietary Inflammatory Potential With Cardiometabolic Risk Factors and Diseases: A Systematic Review and Dose–Response Meta-Analysis of Observational Studies Publisher



Aslani Z^{1, 2} ; Sadeghi O^{1, 2} ; Heidaribeni M³ ; Zahedi H⁴ ; Baygi F⁵ ; Shivappa N^{6, 7, 8} ; Hebert JR^{6, 7, 8} ; Moradi S^{9, 10} ; Sotoudeh G¹ ; Asayesh H¹¹ ; Djalalinia S^{12, 13} ; Qorbani M^{14, 15}
Source: Diabetology and Metabolic Syndrome Published:2020

Abstract

Context: The association of dietary inflammatory index (DII®), as an index of inflammatory quality of diet, with cardiometabolic diseases (CMDs) and risk factors (CMRFs) has been inconsistent in previous studies. Objective: The current systematic review and dose–response meta-analysis was performed to investigate the association of the DII score with CMDs and CMRFs. Data Sources: All published observational studies (cohort, case–control and cross-sectional) using PubMed/Medline, Scopus, ISI Web of Science, and Google Scholar databases were retrieved from inception through November 2019. Data extraction: Two reviewers independently extracted the data from included studies. Data analysis: Pooled hazard ratio (HR) or odds ratio (OR) were calculated by using a random-effects model. Results: Ten prospective cohort studies (total n = 291,968) with 31,069 CMDs-specific mortality, six prospective cohort studies (total n = 43,340) with 1311 CMDs-specific morbidity, two case–control studies with 2140 cases and 6246 controls and one cross-sectional study (total n = 15,613) with 1734 CMDs-specific morbidity were identified for CMDs. Meta-analyses of published observational studies demonstrated that the highest DII score category versus the lowest DII score category was associated with 29% increased risk of CMDs mortality (HR = 1.29; 95% confidence interval (CI) 1.18, 1.41). Moreover, there was a significant association between the DII score and risk of CMDs in cohort studies (HR = 1.35; 95% CI 1.13, 1.61) and non-cohort study (HR = 1.36; 95% CI 1.18, 1.57). We found a significant association between the DII score and metabolic syndrome (MetS) (OR: 1.13; 95% CI 1.03, 1.25), hyperglycemia and hypertension. None-linear dose response meta-analysis showed that there was a significant association between the DII score and risk of CMDs mortality (Pnonlinearity < 0.001). Moreover, evidence of none-linear association between the DII score and risk of CMDs was not observed (p-value = 0.1). Conclusions: Adherence to pro-inflammatory diet was associated with increased risk of CMDs, mortality and MetS. © 2020, The Author(s).